New bi-phosphonate derivative: Synthesis, characterization, antioxidant activity in vitro and via cyclic voltammetry mode and evaluation of its inhibition of SARS-CoV-2 main protease

被引:12
|
作者
Houas, Noudjoud [1 ,2 ]
Kitouni, Siham [1 ,2 ]
Chafai, Nadjib [1 ]
Ghedjati, Samira [3 ]
Djenane, Meriem [1 ]
Tounsi, Assia [4 ]
机构
[1] Univ Ferhat ABBAS Setif 1, Fac Technol, Complex LEMMC Dept Proc Engn, Lab Electrochem Mol Mat, Setif 19000, Algeria
[2] Univ Ferhat Abbas Setif 1, Fac Sci, Dept Chem, Setif 19000, Algeria
[3] Univ Ferhat Abbas Setif 1, Lab Phytotherapy Appl Chron Dis Fac Nat & Life Sci, Setif 19000, Algeria
[4] Univ Ferhat Abbas Setif 1, Dept Proc Engn, Lab Electrochem & Mat LEM, Setif 19000, Algeria
关键词
Synthesis; A-aminophosphonates; Antioxidant activity; Cyclic voltammetry; Molecular docking; OXYGEN; DNA;
D O I
10.1016/j.molstruc.2023.135356
中图分类号
O64 [物理化学(理论化学)、化学物理学];
学科分类号
070304 ; 081704 ;
摘要
In this study, we have synthesized a new molecule labeled HBPA. Its molecular structure was determined by spectroscopic methods such as: FT-IR, NMR (H-1, C-13 and P-31); our compound is subjected to two an-tioxidant activities assays: DPPH scavenging and ferric reducing antioxidant power (FRAP); in the results, HBPA was expanded remarkable inhibition when compared especially to standard BHT with values of 14.936 +/- 0.808 and 7.1486 +/- 0.0645 mu g/ml, respectively; in addition to the scavenging test of superoxide anion integrated in electrochemical process, it elucidated a strongly stable interaction towards the radi-cal by evaluating the thermodynamic descriptors (Gibbs free energy Delta G degrees and the binding constant K-b). Besides, the electrochemical behavior of HBPA was distinguished by an irreversible system and for the electrochemical regime adopted at the surface of the electrode; a diffusion governed by a slow charge transfer was deduced. The molecular docking of HBPA was conducted beside Chloroquine and the obtained results were indicated a significant binding with active sites of the SARS-CoV-2 main protease (M-pro). (C) 2023 Elsevier B.V. All rights reserved.
引用
收藏
页数:9
相关论文
共 29 条
  • [1] Synthesis, characterization, DFT, antioxidant, antibacterial, pharmacokinetics and inhibition of SARS-CoV-2 main protease of some heterocyclic hydrazones
    Adjissi, Lilia
    Chafai, Nadjib
    Benbouguerra, Khalissa
    Kirouani, Imene
    Hellal, Abdelkader
    Layaida, Houdheifa
    Elkolli, Meriem
    Bensouici, Chawki
    Chafaa, Salah
    JOURNAL OF MOLECULAR STRUCTURE, 2022, 1270
  • [2] In Vitro Characterization of Inhibition Function of Calcifediol to the Protease Activity of SARS-COV-2 PLpro
    Chen, Junjie
    Zhang, Yaya
    Zhang, Bingchang
    Wang, Zhanxiang
    JOURNAL OF MEDICAL VIROLOGY, 2024, 96 (11)
  • [3] New α-Hydrazinophosphonic acid: Synthesis, characterization, DFT study and in silico prediction of its potential inhibition of SARS-CoV-2 main protease
    Benbouguerra, Khalissa
    Chafai, Nadjib
    Chafaa, Salah
    Touahria, Youcef Islam
    Tlidjane, Hamida
    JOURNAL OF MOLECULAR STRUCTURE, 2021, 1239
  • [4] Synthesis, in vitro and in silico evaluation of gallamide and selenogallamide derivatives as inhibitors of the SARS-CoV-2 main protease
    de Carvalho, Maryelle A. G.
    Souza, Gabriella B.
    Tizziani, Tiago
    Pontes, Carime L. M.
    Dambros, Bibiana P.
    de Sousa, Natalia F.
    Scotti, Marcus T.
    Steindel, Mario
    Braga, Antonio L.
    Sandjo, Louis P.
    de Assis, Francisco F.
    ARCHIV DER PHARMAZIE, 2024, 357 (11)
  • [5] In vitro inhibition and molecular docking of a new ciprofloxacin-chalcone against SARS-CoV-2 main protease
    Alaaeldin, Rania
    Mustafa, Muhamad
    Abuo-Rahma, Gamal El-Din A.
    Fathy, Moustafa
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2022, 36 (01) : 160 - 170
  • [6] Fluorogenic in vitro activity assay for the main protease Mpro from SARS-CoV-2 and its adaptation to the identification of inhibitors
    Ihssen, Julien
    Faccio, Greta
    Yao, Chunyan
    Sirec, Teja
    Spitz, Urs
    STAR PROTOCOLS, 2021, 2 (03):
  • [7] Biochemical characterization of protease activity of Nsp3 from SARS-CoV-2 and its inhibition by nanobodies
    Armstrong, Lee A.
    Lange, Sven M.
    Cesare, Virginia Dee
    Matthews, Stephen P.
    Nirujogi, Raja Sekhar
    Cole, Isobel
    Hope, Anthony
    Cunningham, Fraser
    Toth, Rachel
    Mukherjee, Rukmini
    Bojkova, Denisa
    Gruber, Franz
    Gray, David
    Wyatt, Paul G.
    Cinatl, Jindrich
    Dikic, Ivan
    Davies, Paul
    Kulathu, Yogesh
    PLOS ONE, 2021, 16 (07):
  • [8] Flavonoids as potential SARS-CoV-2 main protease inhibitors: In vitro activity evaluation, molecular docking, 3D-QSAR investigation and synthesis
    Ren, Shuaiwei
    Liu, Xiaoru
    Huang, Yousheng
    Zhu, Caiqing
    Zhu, Weifeng
    Dong, Huanhuan
    JOURNAL OF MOLECULAR STRUCTURE, 2025, 1321
  • [9] Docking Characterization and in vitro Inhibitory Activity of Flavan-3-ols and Dimeric Proanthocyanidins Against the Main Protease Activity of SARS-Cov-2
    Zhu, Yue
    Xie, De-Yu
    FRONTIERS IN PLANT SCIENCE, 2020, 11
  • [10] Discovery of TCMs and derivatives against the main protease of SARS-CoV-2 via high throughput screening, ADMET analysis, and inhibition assay in vitro
    Qi, Xinyu
    Li, Binglin
    Omarini, Alejandra B.
    Gand, Martin
    Zhang, Xiaoli
    Wang, Jiao
    JOURNAL OF MOLECULAR STRUCTURE, 2022, 1268